(Q51810075)

12 April 2018

title

Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs. (English)

1 reference

12 April 2018

1 reference

3

1 reference

12 April 2018

author name string

Briand F

1

1 reference

12 April 2018

Magot T

2

1 reference

12 April 2018

Nguyen P

4

1 reference

12 April 2018

Ouguerram K

5

1 reference

12 April 2018

publication date

1 April 2006

1 reference

12 April 2018

European Journal of Clinical Investigation

published in

1 reference

12 April 2018

volume

36

1 reference

12 April 2018

issue

4

1 reference

12 April 2018

page(s)

224-230

1 reference

12 April 2018

HDL as a target in the treatment of atherosclerotic cardiovascular disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

High-density lipoproteins as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Selective uptake of high density lipoproteins cholesteryl ester in the dog, a species lacking in cholesteryl ester transfer protein activity; An in vivo approach using stable isotopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Lipoproteins abnormalities in obese insulin-resistant dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Lowering of serum cholesteryl ester transfer protein--but not lecithin:cholesterol acyltransferase--activity levels by hypocholesterolemic drugs in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

21 January 2018

Update on statins: 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01622.X

10.1111/J.1365-2362.2006.01622.X

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

1 reference

12 April 2018